-
1
-
-
41349099104
-
Cancer statistics, 2008
-
DOI 10.3322/CA.2007.0010
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96. (Pubitemid 351521864)
-
(2008)
CA Cancer Journal for Clinicians
, vol.58
, Issue.2
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
Thun, M.J.7
-
2
-
-
17644427902
-
-
American Cancer Society. Atlanta: American Cancer Society.
-
American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society; 2006.
-
(2006)
Cancer Facts and Figures 2006
-
-
-
3
-
-
17144407950
-
4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells
-
DOI 10.1074/jbc.M409811200
-
Paruchuri S, Broom O, Dib K, Sjölander A,. The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Rac-dependent migration of intestinal epithelial cells. J Biol Chem 2005; 280: 13538-44. (Pubitemid 40517245)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.14
, pp. 13538-13544
-
-
Paruchuri, S.1
Broom, O.2
Dib, K.3
Sjolander, A.4
-
4
-
-
0020597565
-
Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation
-
Samuelsson B,. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-75. (Pubitemid 13130140)
-
(1983)
Science
, vol.220
, Issue.4597
, pp. 568-575
-
-
Samuelsson, B.1
-
5
-
-
3242807236
-
Cysteinyl leukotrienes and their receptors: Cellular distribution and function in immune and inflammatory responses
-
Kanaoka Y, Boyce JA,. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol 2004; 173: 1503-10. (Pubitemid 38971578)
-
(2004)
Journal of Immunology
, vol.173
, Issue.3
, pp. 1503-1510
-
-
Kanaoka, Y.1
Boyce, J.A.2
-
6
-
-
33751113286
-
Leukotriene receptors in atherosclerosis
-
DOI 10.1080/07853890600982737, PII V107T217W909J716
-
Back M, Hansson GK,. Leukotriene receptors in atherosclerosis. Ann Med 2006; 38: 493-502. (Pubitemid 44764437)
-
(2006)
Annals of Medicine
, vol.38
, Issue.7
, pp. 493-502
-
-
Back, M.1
Hansson, G.K.2
-
7
-
-
0033600291
-
1 receptor
-
DOI 10.1038/21658
-
Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399: 789-93. (Pubitemid 29293175)
-
(1999)
Nature
, vol.399
, Issue.6738
, pp. 789-793
-
-
Lynch, K.R.1
O'Neill, G.P.2
Liu, Q.3
Im, D.-S.4
Sawyer, N.5
Metters, K.M.6
Coulombe, N.7
Abramovitz, M.8
Figueroa, D.J.9
Zeng, Z.10
Connolly, B.M.11
Bai, C.12
Austin, C.P.13
Chateauneuf, A.14
Stocco, R.15
Greig, G.M.16
Kargman, S.17
Hooks, S.B.18
Hosfield, E.19
Williams Jr., D.L.20
Ford-Hutchinson, A.W.21
Caskey, C.T.22
Evans, J.F.23
more..
-
8
-
-
0034730638
-
Characterization of the human cysteinyl leukotriene 2 receptor
-
Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, Stocco R, Bellefeuille JN, Abramovitz M, Cheng R, Williams DL, Jr, Zeng Z, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000; 275: 30531-6.
-
(2000)
J Biol Chem
, vol.275
, pp. 30531-30536
-
-
Heise, C.E.1
O'Dowd, B.F.2
Figueroa, D.J.3
Sawyer, N.4
Nguyen, T.5
Im, D.S.6
Stocco, R.7
Bellefeuille, J.N.8
Abramovitz, M.9
Cheng, R.10
Williams Jr., D.L.11
Zeng, Z.12
-
9
-
-
0035901090
-
Inflammation and cancer: Back to Virchow?
-
DOI 10.1016/S0140-6736(00)04046-0
-
Balkwill F, Mantovani A,. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-45. (Pubitemid 32173595)
-
(2001)
Lancet
, vol.357
, Issue.9255
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
10
-
-
67549125238
-
Gene expression profiling of the tumor microenvironment during breast cancer progression
-
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC,. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 2009; 11: R7.
-
(2009)
Breast Cancer Res
, vol.11
-
-
Ma, X.J.1
Dahiya, S.2
Richardson, E.3
Erlander, M.4
Sgroi, D.C.5
-
11
-
-
0035902141
-
The microenvironment of the tumour-host interface
-
Liotta LA, Kohn EC,. The microenvironment of the tumour-host interface. Nature 2001; 411: 375-9.
-
(2001)
Nature
, vol.411
, pp. 375-379
-
-
Liotta, L.A.1
Kohn, E.C.2
-
12
-
-
0037207863
-
1, COX-2, and other cell survival factors in colorectal adenocarcinomas
-
DOI 10.1053/gast.2003.50011
-
Öhd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H, Sjölander A,. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003; 124: 57-70. (Pubitemid 36055339)
-
(2003)
Gastroenterology
, vol.124
, Issue.1
, pp. 57-70
-
-
Ohd, J.F.1
Nielsen, C.K.2
Campbell, J.3
Landberg, G.4
Lofberg, H.5
Sjolander, A.6
-
13
-
-
0242413115
-
4 Mediates Survival and Proliferation via Separate but Parallel Pathways in the Human Intestinal Epithelial Cell Line Int 407
-
DOI 10.1074/jbc.M302881200
-
Paruchuri S, Sjölander A,. Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal Epithelial cell line Int 407. J Biol Chem 2003; 278: 45577-85. (Pubitemid 37432699)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.46
, pp. 45577-45585
-
-
Paruchuri, S.1
Sjolander, A.2
-
14
-
-
0033778357
-
Leukotrienes induce cell-survival signaling in intestinal epithelial cells
-
Öhd JF, Wikström K, Sjölander A,. Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 2000; 119: 1007-18.
-
(2000)
Gastroenterology
, vol.119
, pp. 1007-1018
-
-
Öhd, J.F.1
Wikström, K.2
Sjölander, A.3
-
15
-
-
35148834706
-
An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation
-
DOI 10.1158/0008-5472.CAN-07-0771
-
Magnusson C, Ehrnström R, Olsen J, Sjölander A,. An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation. Cancer Res 2007; 67: 9190-8. (Pubitemid 47535905)
-
(2007)
Cancer Research
, vol.67
, Issue.19
, pp. 9190-9198
-
-
Magnusson, C.1
Ehrnstrom, R.2
Olsen, J.3
Sjolander, A.4
-
16
-
-
36148941367
-
1 receptors and down-modulate cysteinyl leukotriene-dependent mitogenic responses of mast cells
-
DOI 10.1182/blood-2007-07-100453
-
Jiang Y, Borrelli LA, Kanaoka Y, Bacskai BJ, Boyce JA,. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 2007; 110: 3263-70. (Pubitemid 350106319)
-
(2007)
Blood
, vol.110
, Issue.9
, pp. 3263-3270
-
-
Jiang, Y.1
Borrelli, L.A.2
Kanaoka, Y.3
Bacskai, B.J.4
Boyce, J.A.5
-
17
-
-
2942676455
-
Estrogens and their receptors in breast cancer progression: A dual role in cancer proliferation and invasion
-
DOI 10.1016/j.critrevonc.2004.02.001, PII S1040842804000320
-
Platet N, Cathiard AM, Gleizes M, Garcia M,. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004; 51: 55-67. (Pubitemid 38781751)
-
(2004)
Critical Reviews in Oncology/Hematology
, vol.51
, Issue.1
, pp. 55-67
-
-
Platet, N.1
Cathiard, A.M.2
Gleizes, M.3
Garcia, M.4
-
18
-
-
0037440261
-
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer
-
Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst 2003; 95: 142-53. (Pubitemid 36193263)
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.2
, pp. 142-153
-
-
Konecny, G.1
Pauletti, G.2
Pegram, M.3
Untch, M.4
Dandekar, S.5
Aguilar, Z.6
Wilson, C.7
Rong, H.-M.8
Bauerfeind, I.9
Felber, M.10
Wang, H.-J.11
Beryt, M.12
Seshadri, R.13
Hepp, H.14
Slamon, D.J.15
-
19
-
-
29544433211
-
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
-
DOI 10.1056/NEJMoa052258
-
Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 2005; 353: 2747-57. (Pubitemid 43016814)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.26
, pp. 2747-2757
-
-
Thurlimann, B.1
Keshaviah, A.2
Coates, A.S.3
Mouridsen, H.4
Mauriac, L.5
Forbes, J.F.6
Paridaens, R.7
Castiglione-Gertsch, M.8
Gelber, R.D.9
Rabaglio, M.10
Smith, I.11
Wardly, A.12
Price, K.N.13
Goldhirsch, A.14
-
20
-
-
0347519223
-
Epidemiology of breast cancer - Selected highlights
-
DOI 10.1016/S0960-9776(03)00144-9
-
Cuzick J,. Epidemiology of breast cancer - selected highlights. Breast 2003; 12: 405-11. (Pubitemid 38008651)
-
(2003)
Breast
, vol.12
, Issue.6
, pp. 405-411
-
-
Cuzick, J.1
-
21
-
-
0642375461
-
Aromatase inhibitors in prevention - Data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study)
-
discussion 264-6.
-
Cuzick J,. Aromatase inhibitors in prevention - data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study). Recent Results Cancer Res 2003; 163: 96-103; discussion 264-6.
-
(2003)
Recent Results Cancer Res
, vol.163
, pp. 96-103
-
-
Cuzick, J.1
-
22
-
-
56449095636
-
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer
-
Helczynska K, Larsson AM, Holmquist Mengelbier L, Bridges E, Fredlund E, Borgquist S, Landberg G, Påhlman S, Jirström K,. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 2008; 68: 9212-20.
-
(2008)
Cancer Res
, vol.68
, pp. 9212-9220
-
-
Helczynska, K.1
Larsson, A.M.2
Holmquist Mengelbier, L.3
Bridges, E.4
Fredlund, E.5
Borgquist, S.6
Landberg, G.7
Påhlman, S.8
Jirström, K.9
-
23
-
-
13544260860
-
1 receptor in the nucleus of colorectal adenocarcinoma cells
-
Nielsen CK, Campbell JI, Öhd JF, Mörgelin M, Riesbeck K, Landberg G, Sjölander A,. A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 2005; 65: 732-42. (Pubitemid 40220345)
-
(2005)
Cancer Research
, vol.65
, Issue.3
, pp. 732-742
-
-
Nielsen, C.K.1
Campbell, J.I.A.2
Ohd, J.F.3
Morgelin, M.4
Riesbeck, K.5
Landberg, G.6
Sjolander, A.7
-
24
-
-
0026072872
-
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
-
Elston CW, Ellis IO,. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
-
(1991)
Histopathology
, vol.19
, pp. 403-410
-
-
Elston, C.W.1
Ellis, I.O.2
-
25
-
-
0032559562
-
CAS/Crk coupling serves as a 'molecular switch' for induction of cell migration
-
DOI 10.1083/jcb.140.4.961
-
Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA,. CAS/Crk coupling serves as a "molecular switch" for induction of cell migration. J Cell Biol 1998; 140: 961-72. (Pubitemid 28141232)
-
(1998)
Journal of Cell Biology
, vol.140
, Issue.4
, pp. 961-972
-
-
Klemke, R.L.1
Leng, J.2
Molander, R.3
Brooks, P.C.4
Vuori, K.5
Cheresh, D.A.6
-
26
-
-
33847368681
-
Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands
-
DOI 10.1096/fj.06-6624hyp
-
Goetzl EJ,. Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. FASEB J 2007; 21: 638-42. (Pubitemid 46348269)
-
(2007)
FASEB Journal
, vol.21
, Issue.3
, pp. 638-642
-
-
Goetzl, E.J.1
-
27
-
-
33847328744
-
Distinctive T cell-suppressive signals from nuclearized type 1 sphingosine 1-phosphate G protein-coupled receptors
-
DOI 10.1074/jbc.M608597200
-
Liao JJ, Huang MC, Graler M, Huang Y, Qiu H, Goetzl EJ,. Distinctive T cell-suppressive signals from nuclearized type 1 sphingosine 1-phosphate G protein-coupled receptors. J Biol Chem 2007; 282: 1964-72. (Pubitemid 47076725)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.3
, pp. 1964-1972
-
-
Liao, J.-J.1
Huang, M.-C.2
Graler, M.3
Huang, Y.4
Qiu, H.5
Goetzl, E.J.6
-
28
-
-
0141755203
-
Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1
-
DOI 10.1074/jbc.M212481200
-
Gobeil F, Jr, Bernier SG, Vazquez-Tello A, Brault S, Beauchamp MH, Quiniou C, Marrache AM, Checchin D, Sennlaub F, Hou X, Nader M, Bkaily G, et al. Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J Biol Chem 2003; 278: 38875-83. (Pubitemid 37221787)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.40
, pp. 38875-38883
-
-
Gobeil Jr., F.1
Bernier, S.G.2
Vazquez-Tello, A.3
Brault, S.4
Beauchamp, M.H.5
Quiniou, C.6
Marrache, A.M.7
Checchin, D.8
Sennlaub, F.9
Hou, X.10
Nader, M.11
Bkaily, G.12
Ribeiro-da-Silva, A.13
Goetzl, E.J.14
Chemtob, S.15
-
29
-
-
0034041537
-
Nuclear targeting signal recognition: A key control point in nuclear transport?
-
DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O
-
Jans DA, Xiao CY, Lam MH,. Nuclear targeting signal recognition: a key control point in nuclear transport? Bioessays 2000; 66: 532-44. (Pubitemid 30387974)
-
(2000)
BioEssays
, vol.22
, Issue.6
, pp. 532-544
-
-
Jans, D.A.1
Xiao, C.-Y.2
Lam, M.H.C.3
-
30
-
-
0028053224
-
Risk of endometrial cancer after tamoxifen treatment of breast cancer
-
DOI 10.1016/S0140-6736(94)92692-1
-
van Leeuwen FE, Benraadt J, Coebergh JW, Kiemeney LA, Gimbrere CH, Otter R, Schouten LJ, Damhuis RA, Bontenbal M, Diepenhorst FW, van den Belt-Dusebout AW, van Tinteren H,. Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994; 343: 448-52. (Pubitemid 24059587)
-
(1994)
Lancet
, vol.343
, Issue.8895
, pp. 448-452
-
-
Van Leeuwen, F.E.1
Benraadt, J.2
Coebergh, J.W.W.3
Kiemeney, L.A.L.M.4
Gimbrere, C.H.F.5
Otter, R.6
Scheuten, L.J.7
Damhuis, R.A.M.8
Bontenbal, M.9
Diepenhorst, F.W.10
Van Den Belt-Dusebout, A.W.11
Van Tinteren, H.12
-
31
-
-
0034626064
-
Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen
-
Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE,. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 2000; 356: 881-7.
-
(2000)
Lancet
, vol.356
, pp. 881-887
-
-
Bergman, L.1
Beelen, M.L.2
Gallee, M.P.3
Hollema, H.4
Benraadt, J.5
Van Leeuwen, F.E.6
-
32
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-717.
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
33
-
-
35848960553
-
Increasing protection after tamoxifen: Insights from the extended adjuvant aromatase inhibitor trials
-
DOI 10.1007/s00432-007-0324-8
-
Rose C,. Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials. J Cancer Res Clin Oncol 2008; 134: 7-17. (Pubitemid 350060693)
-
(2008)
Journal of Cancer Research and Clinical Oncology
, vol.134
, Issue.1
, pp. 7-17
-
-
Rose, C.1
-
34
-
-
0037464769
-
Overview of the main outcomes in breast-cancer prevention trials
-
DOI 10.1016/S0140-6736(03)12342-2
-
Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P,. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003; 361: 296-300. (Pubitemid 36126189)
-
(2003)
Lancet
, vol.361
, Issue.9354
, pp. 296-300
-
-
Cuzick, J.1
Powles, T.2
Veronesi, U.3
Forbes, J.4
Edwards, R.5
Ashley, S.6
Boyle, P.7
-
35
-
-
76049111365
-
Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer
-
Magnusson C, Mezhybovska M, Lörinc E, Fernebro E, Nilbert M, Sjölander A,. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. Eur J Cancer 2010; 46: 826-35.
-
(2010)
Eur J Cancer
, vol.46
, pp. 826-835
-
-
Magnusson, C.1
Mezhybovska, M.2
Lörinc, E.3
Fernebro, E.4
Nilbert, M.5
Sjölander, A.6
-
36
-
-
0033739098
-
Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models
-
Blackwell KL, Haroon ZA, Shan S, Saito W, Broadwater G, Greenberg CS, Dewhirst MW,. Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin Cancer Res 2000; 6: 4359-64.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4359-4364
-
-
Blackwell, K.L.1
Haroon, Z.A.2
Shan, S.3
Saito, W.4
Broadwater, G.5
Greenberg, C.S.6
Dewhirst, M.W.7
-
37
-
-
0037160095
-
Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death
-
DOI 10.1074/jbc.M208092200
-
Obrero M, Yu DV, Shapiro DJ,. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death. J Biol Chem 2002; 277: 45695-703. (Pubitemid 36159182)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.47
, pp. 45695-45703
-
-
Obrero, M.1
Yu, D.V.2
Shapiro, D.J.3
-
38
-
-
0034624260
-
Apoptosis induced by droloxifene and c-myc, bax and bcl-2 mRNA expression in cultured luteal cells of rats
-
Leng Y, Gu ZP, Cao L,. Apoptosis induced by droloxifene and c-myc, bax and bcl-2 mRNA expression in cultured luteal cells of rats. Eur J Pharmacol 2000; 409: 123-31.
-
(2000)
Eur J Pharmacol
, vol.409
, pp. 123-131
-
-
Leng, Y.1
Gu, Z.P.2
Cao, L.3
-
39
-
-
0030006468
-
Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells
-
DOI 10.1074/jbc.271.23.13504
-
Gundimeda U, Chen ZH, Gopalakrishna R,. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 1996; 271: 13504-14. (Pubitemid 26185395)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.23
, pp. 13504-13514
-
-
Gundimeda, U.1
Chen, Z.-H.2
Gopalakrishna, R.3
-
40
-
-
0028070852
-
Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype
-
Bracke ME, Charlier C, Bruyneel EA, Labit C, Mareel MM, Castronovo V,. Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. Cancer Res 1994; 54: 4607-9. (Pubitemid 24276481)
-
(1994)
Cancer Research
, vol.54
, Issue.17
, pp. 4607-4609
-
-
Bracke, M.E.1
Charlier, C.2
Bruyneel, E.A.3
Labit, C.4
Marrel, M.M.5
Castronovo, V.6
|